Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...
In the latest quarter, 4 analysts provided ratings for Omnicell OMCL, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...
Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...
OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning. Omnicell ( NASDAQ:OMCL ) Full ...
Shares of Omnicell stock opened at $38.06 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.22 and a current ratio of 1.37. Omnicell, Inc. has a 52 week low of $25.12 ...
FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported fourth-quarter profit of $15.8 million. On a per-share basis, the Fort Worth, Texas-based company ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BeiGene (ONC – Research Report) and Omnicell (OMCL – Research Report). See what stocks are ...